We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

199 hedge funds and large institutions have $1.06B invested in Editas Medicine in 2018 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 66 increasing their positions, 53 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 53

20% more call options, than puts

Call options by funds: $25.2M | Put options by funds: $20.9M

1.61% more ownership

Funds ownership: 68.05% → 69.66% (+1.6%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

7% less funds holding

Funds holding: 215 → 199 (-16)

8% less capital invested

Capital invested by funds: $1.15B → $1.06B (-$94.5M)

33% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 42

Holders
199
Holders Change
-16
Holders Change %
-7.44%
% of All Funds
4.55%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
28
Increased
66
Reduced
53
Closed
42
Calls
$25.2M
Puts
$20.9M
Net Calls
+$4.22M
Net Calls Change
-$9M

Top Buyers

1
AIM
ARK Investment Management
Florida
+$19.8M
2
VCM
Valiant Capital Management
California
+$12.3M
3
State Street
State Street
Massachusetts
+$10.6M
4
Renaissance Technologies
Renaissance Technologies
New York
+$9.7M
5
CC
Casdin Capital
New York
+$9.1M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$44.3M
2
Morgan Stanley
Morgan Stanley
New York
-$10.9M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$5.09M
4
Capital World Investors
Capital World Investors
California
-$4.91M
5
PIMJS
PKO Investment Management Joint-Stock
Poland
-$4.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$119M +$4.58M +141,609 +4%
BlackRock
2
BlackRock
New York
$114M +$4.33M +134,075 +4%
State Street
3
State Street
Massachusetts
$93M +$10.6M +327,855 +13%
AIM
4
ARK Investment Management
Florida
$88.9M +$19.8M +612,282 +28%
Capital World Investors
5
Capital World Investors
California
$64.7M -$4.91M -152,000 -7%
Morgan Stanley
6
Morgan Stanley
New York
$55.1M -$10.9M -337,312 -16%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$48.5M -$44.3M -1,370,906 -47%
DM
8
Deerfield Management
New York
$36.9M – – –
Viking Global Investors
9
Viking Global Investors
Connecticut
$29.6M – – –
CS
10
Credit Suisse
Switzerland
$24.9M +$7.34M +227,266 +41%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$24.6M -$362K -11,197 -1%
Deutsche Bank
12
Deutsche Bank
Germany
$23M +$8.7M +269,119 +59%
Northern Trust
13
Northern Trust
Illinois
$17.3M +$693K +21,433 +4%
Chevy Chase Trust
14
Chevy Chase Trust
Maryland
$16M +$1.74M +53,991 +12%
Federated Hermes
15
Federated Hermes
Pennsylvania
$15.8M +$6M +185,568 +60%
GTP
16
Global Thematic Partners
New York
$15.3M -$819K -25,349 -5%
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$15M -$2.58M -79,879 -14%
Goldman Sachs
18
Goldman Sachs
New York
$14.7M +$4.08M +126,264 +38%
CC
19
Casdin Capital
New York
$14.6M +$9.1M +281,667 +158%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$14.4M +$230K +7,105 +2%
VCM
21
Valiant Capital Management
California
$12.1M +$12.3M +379,800 New
Renaissance Technologies
22
Renaissance Technologies
New York
$9.55M +$9.7M +300,100 New
TA
23
Teachers Advisors
New York
$8.73M +$135K +4,184 +2%
Charles Schwab
24
Charles Schwab
California
$7.73M +$934K +28,891 +14%
JCM
25
JS Capital Management
New York
$6.97M +$2.42M +75,000 +52%
1
2 3 4 5

EDIT Hedge Fund Activity: Q3 2018 in Review

199 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2018, worth a combined $1.06B — down 8.2% from $1.15B a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of EDIT and 28 opened new positions — a net loss of 14 holders — while 53 trimmed existing stakes and 66 added.

The largest buyer was ARK Investment Management, adding an estimated $19.8M. The largest seller was Fidelity Investments, cutting an estimated $44.3M.

  • 199 institutional investors held Editas Medicine (EDIT) as of Q3 2018, down from 215 in Q2 2018.
  • Funds reported $1.06B of Editas Medicine stock for Q3 2018, down 8.2% quarter-over-quarter.
  • 28 funds opened new Editas Medicine positions in Q3 2018 and 42 closed out, a net change of -14 holders.
  • The largest Editas Medicine buyer in Q3 2018 was ARK Investment Management, an estimated $19.8M added.
  • The largest Editas Medicine seller in Q3 2018 was Fidelity Investments, an estimated $44.3M sold.

Based on aggregated 13F filings for Q3 2018.